SHARE

InnoStars, Accelerator, 2018

EIT Health VentureLab: Start-ups compete with final pitches

18th December 2018

GE Healthcare and Hiventures sign an agreement to support innovative healthcare ventures and initiatives

EIT Health VentureLab’s closing event for 2018 brought more than 80 guests to the A38 Boat in Budapest on 12 December for a “Demo Day”, featuring pitches by participants in the EIT Health Accelerator programme, which is designed to provide start-ups with the entrepreneurial mindset, industrial knowledge and up-to-date business practices they need to succeed.

The winners of the pitch contest were:

  • Disruptive Product prize: Tendertec – looking after our ageing population by creating personalised care technology.
  • Rising Innovator prize: Xvision – a young team aiming to make a strong impact on the world of radiology, on the basis of AI.

Other finalists that pitched that day were Dentica, MindCap, Ariadne, Sineko and Oxipit.

In all, 20 top teams from 14 European countries participated in the EIT Health VentureLab programme, a unique, healthcare-focused accelerator programme that is lead by EIT Health Partner GE Healthcare and is designed to support the professional growth of start-ups created for healthcare solutions. VentureLab teams had participated weekly for 16 weeks in practice-oriented training sessions and received tailored coaching by business experts. Beyond developing their business skills they gained a Europe-wide business and innovator network through EIT Health.

GE Healthcare, Hiventures agree to further cooperation

The event also featured a signing ceremony by GE Healthcare, the EIT Health Partner leading VentureLab, and Hiventures, members of the Hungarian Investment Bank Group. They signed a strategic partnership agreement to jointly support innovative healthcare ventures and initiatives in the future.

“GE Healthcare is one of our core partners and we highly appreciate the partnership established today between GE Healthcare and Hiventures, an exemplary cooperation between industry and investors,” said Kurt Höller, Director of Business Creation at EIT Health.

AI tool for COVID-19 produces significant results

AI tool for COVID-19 produces significant results

EIT Health project aids personalised medicine

Find out more

EIT Health helps Tubulis secure €10.7M in funding

EIT Health helps Tubulis secure €10.7M in funding

Investor Network aids firm doing antibody work

Find out more

EIT Health-backed start-ups garner big investments

EIT Health-backed start-ups garner big investments

A million each for iLoF and Restorative Neurotechnologies

Find out more